Literature DB >> 9220159

Immune response to the mannose-sensitive hemagglutinin in patients with cholera due to Vibrio cholerae O1 and O0139.

F Qadri1, G Jonson, Y A Begum, C Wennerås, M J Albert, M A Salam, A M Svennerholm.   

Abstract

The mannose-sensitive hemagglutinin (MSHA) is a type 4 pilus present in Vibrio cholerae O1 strains of the El Tor biotype, as well as in strains of serogroup O139. It has been shown to be a colonization antigen in animal models. The aim of this study was to investigate systemic and local antibody responses to MSHA in adult patients with cholera due to V. cholerae O1 and O139. Twenty-four of 28 (86%) patients with O1 cholera and 11 of 17 (65%) patients with O139 cholera showed significant increases in MSHA-specific immunoglobulin A (IgA) and IgM antibody-secreting cells (ASCs) 7 days after the onset of disease. However, the magnitude of the ASC response in O1 cholera patients was significantly higher than that in the O139 cholera patients in both IgA-producing (P = 0.015) and IgM-producing (P = 0.029) cells. Both groups of patients responded with antibody responses to MSHA in plasma, seroconverting with both IgA (63 to 70% of patients) and IgG (43 to 59% of patients) antibodies. Compared to the MSHA-specific antibody levels determined in healthy controls (n = 10), more than 90% of O1 and O139 cholera patients showed responses to MSHA of both the IgA and the IgG isotypes. About 70% of the patients in both groups also had antibody responses to MSHA in their feces. In summary, we demonstrated that MSHA is immunogenic, giving rise to both systemic and local antibodies in patients with cholera due to both O1 and O139 serogroups.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9220159      PMCID: PMC170545          DOI: 10.1128/cdli.4.4.429-434.1997

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  31 in total

1.  A highly selective gelatin-taurocholate-tellurite medium for the isolation of Vibrio cholerae.

Authors:  K A MONSUR
Journal:  Trans R Soc Trop Med Hyg       Date:  1961-09       Impact factor: 2.184

2.  Immune response to acute diarrhea seen as circulating antibody-secreting cells.

Authors:  A M Kantele; R Takanen; H Arvilommi
Journal:  J Infect Dis       Date:  1988-11       Impact factor: 5.226

3.  A novel two colour ELISPOT assay. I. Simultaneous detection of distinct types of antibody-secreting cells.

Authors:  C Czerkinsky; Z Moldoveanu; J Mestecky; L A Nilsson; O Ouchterlony
Journal:  J Immunol Methods       Date:  1988-11-25       Impact factor: 2.303

4.  Expression and detection of different biotype-associated cell-bound haemagglutinins of Vibrio cholerae O1.

Authors:  G Jonson; J Sanchez; A M Svennerholm
Journal:  J Gen Microbiol       Date:  1989-01

5.  Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease.

Authors:  M Jertborn; A M Svennerholm; J Holmgren
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 5.948

6.  Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory.

Authors:  M Quiding; I Nordström; A Kilander; G Andersson; L A Hanson; J Holmgren; C Czerkinsky
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

7.  Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin.

Authors:  R K Taylor; V L Miller; D B Furlong; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

8.  Cloning and sequencing of Vibrio cholerae mannose-sensitive haemagglutinin pilin gene: localization of mshA within a cluster of type 4 pilin genes.

Authors:  G Jonson; M Lebens; J Holmgren
Journal:  Mol Microbiol       Date:  1994-07       Impact factor: 3.501

9.  Rapid diagnosis of cholera by coagglutination test using 4-h fecal enrichment cultures.

Authors:  M Rahman; D A Sack; S Mahmood; A Hossain
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

10.  Local and systemic antibody responses to naturally acquired enterotoxigenic Escherichia coli diarrhea in an endemic area.

Authors:  B J Stoll; A M Svennerholm; L Gothefors; D Barua; S Huda; J Holmgren
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

View more
  24 in total

1.  Enterotoxin-specific immunoglobulin E responses in humans after infection or vaccination with diarrhea-causing enteropathogens.

Authors:  F Qadri; M Asaduzzaman; C Wennerås; G Mohi; M J Albert; M Abdus Salam; R B Sack; M Jertborn; J R McGhee; D A Sack; J Holmgren
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  Bifidobacterium Abundance in Early Infancy and Vaccine Response at 2 Years of Age.

Authors:  M Nazmul Huda; Shaikh M Ahmad; M Jahangir Alam; Afsana Khanam; Karen M Kalanetra; Diana H Taft; Rubhana Raqib; Mark A Underwood; David A Mills; Charles B Stephensen
Journal:  Pediatrics       Date:  2019-02       Impact factor: 7.124

3.  Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with cholera.

Authors:  Taher Uddin; Amena Aktar; Peng Xu; Russell A Johnson; M Arifur Rahman; Daniel T Leung; Sadia Afrin; Aklima Akter; Mohammad Murshid Alam; Atiqur Rahman; Fahima Chowdhury; Ashraful I Khan; Taufiqur Rahman Bhuiyan; Meagan K Bufano; Rasheduzzaman Rashu; Yanan Yu; Ying Wu-Freeman; Jason B Harris; Regina C LaRocque; Richelle C Charles; Pavol Kováč; Stephen B Calderwood; Edward T Ryan; Firdausi Qadri
Journal:  Am J Trop Med Hyg       Date:  2014-03-31       Impact factor: 2.345

4.  Lipopolysaccharide- and cholera toxin-specific subclass distribution of B-cell responses in cholera.

Authors:  F Qadri; F Ahmed; M M Karim; C Wenneras; Y A Begum; M Abdus Salam; M J Albert; J R McGhee
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

5.  Cryptosporidiosis in HIV/AIDS patients in Kenya: clinical features, epidemiology, molecular characterization and antibody responses.

Authors:  Jane W Wanyiri; Henry Kanyi; Samuel Maina; David E Wang; Aaron Steen; Paul Ngugi; Timothy Kamau; Tabitha Waithera; Roberta O'Connor; Kimani Gachuhi; Claire N Wamae; Mkaya Mwamburi; Honorine D Ward
Journal:  Am J Trop Med Hyg       Date:  2014-05-27       Impact factor: 2.345

6.  Cholera caused by Vibrio cholerae O1 induces T-cell responses in the circulation.

Authors:  Taufiqur Rahman Bhuiyan; Samuel B Lundin; Ashraful Islam Khan; Anna Lundgren; Jason B Harris; Stephen B Calderwood; Firdausi Qadri
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

7.  Antibody responses in humans against coli surface antigen 6 of enterotoxigenic Escherichia coli.

Authors:  A Helander; C Wennerås; F Qadri; A M Svennerholm
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  The major subunit of the toxin-coregulated pilus TcpA induces mucosal and systemic immunoglobulin A immune responses in patients with cholera caused by Vibrio cholerae O1 and O139.

Authors:  Muhammad Asaduzzaman; Edward T Ryan; Manohar John; Long Hang; Ashraful I Khan; A S G Faruque; Ronald K Taylor; Stephen B Calderwood; Firdausi Qadri
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

9.  Memory T-cell responses to Vibrio cholerae O1 infection.

Authors:  Ana A Weil; Mohammad Arifuzzaman; Taufiqur R Bhuiyan; Regina C LaRocque; Aaron M Harris; Emily A Kendall; Azim Hossain; Abdullah A Tarique; Alaullah Sheikh; Fahima Chowdhury; Ashraful I Khan; Farhan Murshed; Kenneth C Parker; Kalyan K Banerjee; Edward T Ryan; Jason B Harris; Firdausi Qadri; Stephen B Calderwood
Journal:  Infect Immun       Date:  2009-08-24       Impact factor: 3.441

10.  Complexity of rice-water stool from patients with Vibrio cholerae plays a role in the transmission of infectious diarrhea.

Authors:  Eric J Nelson; Ashrafuzzaman Chowdhury; Jason B Harris; Yasmin A Begum; Fahima Chowdhury; Ashraful I Khan; Regina C Larocque; Anne L Bishop; Edward T Ryan; Andrew Camilli; Firdausi Qadri; Stephen B Calderwood
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.